[Clinical Application and Limitations of Myeloma Response Assessment and Diagnosis System (MY-RADS)]
{{output}}
Multiple myeloma, which is a proliferative disease of plasma cells that originate from a single clone, is the second most common hematologic malignancy following non-Hodgkin lymphoma. In the past, its diagnosis was made based on clinical findings (so-called "C... ...